Molecular modulators of CDK4/6 inhibitor response in experimental glioma identified through genome-wide CRISPR-Cas9 screening

dc.contributor.author	Haeusser, Lara A.
dc.contributor.author	Kuhlburger, Laurence
dc.contributor.author	Tsiami, Foteini
dc.contributor.author	Nahnsen, Sven
dc.contributor.author	Beck, Susanne
dc.contributor.author	Merk, Daniel J.
dc.contributor.author	Tabatabai, Ghazaleh
dc.date.accessioned	2026-06-01T10:00:42Z
dc.date.available	2026-06-01T10:00:42Z
dc.date.issued	2026-05-04
dc.identifier.issn	1522-8517
dc.identifier.uri	http://hdl.handle.net/10900/180149
dc.language.iso	en	de_DE
dc.publisher	Oxford University Press	de_DE
dc.relation.uri	https://doi.org/10.1093/neuonc/noag093	de_DE
dc.subject.ddc	004	de_DE
dc.title	Molecular modulators of CDK4/6 inhibitor response in experimental glioma identified through genome-wide CRISPR-Cas9 screening	de_DE
dc.type	Article	de_DE
utue.personen.roh	Surender, Surender
utue.personen.roh	Haeusser, Lara Annina
utue.personen.roh	Kuhlburger, Laurence
utue.personen.roh	Tsiami, Foteini
utue.personen.roh	Dogan, Nihal Olcay
utue.personen.roh	Maise, Louise
utue.personen.roh	Nahnsen, Sven
utue.personen.roh	Beck, Susanne
utue.personen.roh	Merk, Daniel Josef
utue.personen.roh	Tabatabai, Ghazaleh
dcterms.isPartOf.ZSTitelID	Neuro-Oncology	de_DE